Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_assertion type Assertion NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_head.
- NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_assertion description "[This review summarizes the rationale for blockade of angiotensin II as a therapeutic target in treating diabetic kidney disease, including the critical role played by podocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_provenance.
- NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_assertion evidence source_evidence_literature NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_provenance.
- NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_assertion SIO_000772 21067505 NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_provenance.
- NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_assertion wasDerivedFrom befree-2016 NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_provenance.
- NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_assertion wasGeneratedBy ECO_0000203 NP851673.RAEfm8yzopVzp1dBPJ_88aLaOepfSW5JdEE1R1wRBW8-U130_provenance.